Issue 5/2011
Content (6 Articles)
Nutrition therapy cost analysis in the US
Robin S. Turpin, Todd Canada, Frank Xiaoqing Liu, Catherine J. Mercaldi, Alessandro Pontes-Arruda, Paul Wischmeyer
Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population
Noam Y. Kirson, Howard G. Birnbaum, Jasmina I. Ivanova, Tracy Waldman, Vijay Joish, Todd Williamson
Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE Clinical trial
Michael W. Kattan, Stephanie R. Earnshaw, Cheryl L. McDade, Libby K. Black, Gerald L. Andriole
Assessing quality of life among British older people using the ICEPOP CAPability (ICECAP-O) measure
Terry N. Flynn, Phil Chan, Joanna Coast, Tim J. Peters
Early assessment of medical technologies to inform product development and market access
Maarten J. Ijzerman, Lotte M. G. Steuten
Erratum to: Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis
D. Mueller, A. Gandjour